Global Genome Editing Market 2018-2022

ゲノム編集の世界市場2018-2022

◆タイトル:Global Genome Editing Market 2018-2022
◆商品コード:IRTNTR21381
◆調査・発行会社:Technavio (Infiniti Research Ltd.)
◆発行日:2018年4月18日
◆ページ数:117
◆資料形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:New Research Areas
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,500 ⇒換算¥385,000見積依頼/購入/質問フォーム
Five User(5名様閲覧用)USD4,000 ⇒換算¥440,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD5,000 ⇒換算¥550,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、資料に記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はTechnavio (Infiniti Research Ltd.)の日本における正規販売代理店です。

【資料の概要】

当調査レポートでは、ゲノム編集の世界市場について調査・分析し、市場概要、市場環境、ゲノム編集市場規模、最終用途別(バイオテクノロジー・医薬品企業、学術機関・調査研究機関、CRO)分析、市場動向、競争環境、主要地域別市場規模(アメリカ、ヨーロッパ、アジアなど)、関連企業情報などを含め、以下の構成でお届け致します。
・エグゼクティブサマリー
・調査範囲・調査手法
・ゲノム編集の世界市場概要
・ゲノム編集の世界市場環境
・ゲノム編集の世界市場動向
・ゲノム編集の世界市場規模
・ゲノム編集の世界市場:業界構造分析
・ゲノム編集の世界市場:最終用途別(バイオテクノロジー・医薬品企業、学術機関・調査研究機関、CRO)
・ゲノム編集の世界市場:地域別市場規模・分析
・ゲノム編集のアメリカ市場規模・予測
・ゲノム編集のヨーロッパ市場規模・予測
・ゲノム編集のアジア市場規模・予測
・ゲノム編集の主要国分析
・ゲノム編集の世界市場:意思決定フレームワーク
・ゲノム編集の世界市場:成長要因、課題
・ゲノム編集の世界市場:競争環境
・ゲノム編集の世界市場:関連企業情報(ベンダー分析)

About Genome Editing

Genome editing is a type of genetic engineering technique that involves insertions, deletions, replacements or modifications of DNA in the genomes of living organisms.

Technavio’s analysts forecast the global genome editing market to grow at a CAGR of 15.6% during the period 2018-2022.

Covered in this report
The report covers the present scenario and the growth prospects of the global genome editing market for 2018-2022. To calculate the market size, the report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources.

The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA

Technavio’s report, Global Genome Editing Market 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
• Genscript
• Horizon Discovery Group
• Lonza
• Merck KGaA
• Sangamo Therapeutics
• Thermo Fisher Scientific

Market driver
• Increase in applications of genome editing in therapeutics
• For a full, detailed list, view our report

Market challenge
• Lack of trained laboratory professionals
• For a full, detailed list, view our report

Market trend
• Global initiatives encouraging proteomics research
• For a full, detailed list, view our report

Key questions answered in this report
• What will the market size be in 2022 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?

You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.

【資料の目次】

PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
PART 03: RESEARCH METHODOLOGY
PART 04: MARKET LANDSCAPE
• Market ecosystem
• Market characteristics
• Market segmentation analysis
PART 05: MARKET SIZING
• Market definition
• Market sizing 2017
• Market size and forecast 2017-2022
PART 06: FIVE FORCES ANALYSIS
• Bargaining power of buyers
• Bargaining power of suppliers
• Threat of new entrants
• Threat of substitutes
• Threat of rivalry
• Market condition
PART 07: MARKET SEGMENTATION BY END-USER
• Segmentation by end-user
• Comparison by end-user
• Biotechnology and pharmaceutical companies
• Academic institutes and research laboratories
• CROs
• Market opportunity by end-user
PART 08: CUSTOMER LANDSCAPE
PART 09: REGIONAL LANDSCAPE
• Geographical segmentation
• Regional comparison
• Americas
• EMEA
• APAC
• Market opportunity
PART 10: DECISION FRAMEWORK
PART 11: DRIVERS AND CHALLENGES
• Market drivers
• Market challenges
PART 12: MARKET TRENDS
• Technological advancement in genome editing tools
• Global initiatives encouraging proteomics research
• Advances in genome editing tools to improve development of vaccines
PART 13: VENDOR LANDSCAPE
• Overview
• Landscape disruption
PART 14: VENDOR ANALYSIS
• Vendors covered
• Vendor classification
• Market positioning of vendors
• Genscript
• Horizon Discovery Group
• Lonza
• Merck KGaA
• Sangamo Therapeutics
• Thermo Fisher Scientific
PART 15: APPENDIX
• List of abbreviations
Exhibit 01: Parent market
Exhibit 02: Global genomics market
Exhibit 03: Market characteristics
Exhibit 04: Market segments
Exhibit 05: Market definition – Inclusions and exclusions checklist
Exhibit 06: Market size 2017
Exhibit 07: Validation techniques employed for market sizing 2017
Exhibit 08: Global genome editing market– Market size and forecast 2017-2022 ($ mn)
Exhibit 09: Global genome editing market– Year-over-year growth 2018-2022 (%)
Exhibit 10: Five forces analysis 2017
Exhibit 11: Five forces analysis 2022
Exhibit 12: Bargaining power of buyers
Exhibit 13: Bargaining power of suppliers
Exhibit 14: Threat of new entrants
Exhibit 15: Threat of substitutes
Exhibit 16: Threat of rivalry
Exhibit 17: Market condition – Five forces 2017 and 2022
Exhibit 18: End-user – Market share 2017-2022 (%)
Exhibit 19: Comparison by end-user
Exhibit 20: Biotechnology and pharmaceutical companies– Market size and forecast 2017-2022 ($ mn)
Exhibit 21: Biotechnology and pharmaceutical companies – Year-over-year growth 2018-2022 (%)
Exhibit 22: Academic institutes and research laboratories – Market size and forecast 2017- 2022 ($ mn)
Exhibit 23: Academic institutes and research laboratories – Year-over-year growth 2018-2022 (%)
Exhibit 24: CROs – Market size and forecast 2017-2022 ($ mn)
Exhibit 25: CROs – Year-over-year growth 2018-2022 (%)
Exhibit 26: Market opportunity by end-user
Exhibit 27: Customer landscape
Exhibit 28: Global – Market share by geography 2017-2022 (%)
Exhibit 29: Regional comparison
Exhibit 30: Americas – Market size and forecast 2017-2022 ($ mn)
Exhibit 31: Americas – Year-over-year growth 2018-2022 (%)
Exhibit 32: Top 3 countries in Americas
Exhibit 33: EMEA- Market size and forecast 2017-2022 ($ mn)
Exhibit 34: EMEA – Year-over-year growth 2018-2022 (%)
Exhibit 35: Top 3 countries in EMEA
Exhibit 36: APAC – Market size and forecast 2017-2022 ($ mn)
Exhibit 37: APAC – Year-over-year growth 2018-2022 (%)
Exhibit 38: Top 3 countries in APAC
Exhibit 39: Market opportunity
Exhibit 40: Vendor landscape
Exhibit 41: Landscape disruption
Exhibit 42: Vendors covered
Exhibit 43: Vendor classification
Exhibit 44: Market positioning of vendors
Exhibit 45: Genscript overview
Exhibit 46: GenScript – Business segments
Exhibit 47: GenScript – Organizational developments
Exhibit 48: Genscript– Geographic focus
Exhibit 49: Genscript – Segment focus
Exhibit 50: Genscript – Key offerings
Exhibit 51: Horizon Discovery Group overview
Exhibit 52: Horizon Discovery Group – Business segments
Exhibit 53: Horizon Discovery Group – Organizational developments
Exhibit 54: Horizon Discovery Group – Geographic focus
Exhibit 55: Horizon Discovery Group – Segment focus
Exhibit 56: Horizon Discovery Group – Key offerings
Exhibit 57: Lonza overview
Exhibit 58: Lonza – Business segments
Exhibit 59: Lonza – Organizational developments
Exhibit 60: Lonza – Geographic focus
Exhibit 61: Lonza – Segment focus
Exhibit 62: Lonza – Key offerings
Exhibit 63: Merck KGaA overview
Exhibit 64: Merck KGaA– Business segments
Exhibit 65: Merck KGaA – Organizational developments
Exhibit 66: Merck KGaA – Geographic focus
Exhibit 67: Merck KGaA – Segment focus
Exhibit 68: Merck KGaA – Key offerings
Exhibit 69: Sangamo Therapeutics overview
Exhibit 70: Sangamo Therapeutics– Business segments
Exhibit 71: Sangamo Therapeutics– Organizational developments
Exhibit 72: Sangamo Therapeutics – Geographic focus
Exhibit 73: Sangamo Therapeutics – Segment focus
Exhibit 74: Sangamo Therapeutics – Key offerings
Exhibit 75: Thermo Fisher Scientific overview
Exhibit 76: Thermo Fisher Scientific – Business segments
Exhibit 77: Thermo Fisher Scientific – Organizational developments
Exhibit 78: Thermo Fisher Scientific – Geographic focus
Exhibit 79: Thermo Fisher Scientific – Segment focus
Exhibit 80: Thermo Fisher Scientific – Key offerings



【掲載企業】

Genscript, Horizon Discovery Group, Lonza, Merck KGaA, Sangamo Therapeutics, and Thermo Fisher Scientific.

★調査レポート[ゲノム編集の世界市場2018-2022] (Global Genome Editing Market 2018-2022 / IRTNTR21381)販売に関する免責事項
[ゲノム編集の世界市場2018-2022] (Global Genome Editing Market 2018-2022 / IRTNTR21381)についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆